Chimerix reported -14563000 in EBIT for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Ardelyx ARDX:US $ -32005000 4.36M
Chimerix CMRX:US -14563000 2.81M
Curis CRIS:US $ -8800000 2.52M
Dynavax Technologies DVAX:US $ 29.01M 40.65M
Emergent Biosolutions EBS:US $ 95.4M 166.2M
Gilead Sciences GILD:US $ 2912M 261M
Glaxosmithkline GSK:US 1.68B 59M
Life Technologies LIFE:US $ -7202000 2.26M
Merk MRK:US $ 4290M 4007M
Mirati Therapeutics MRTX:US $ -132421000 26.09M
Novavax NVAX:US $ -208632000 25.78M
Xoma XOMA:US $ -6427000 30.3M